Suchergebnisse

Millistjórnendur eru í krefjandi hlutverki og upplifa sig oft eins og milli steins og sleggju. Þeir gegna þungavigtarhlutverki en störf þeirra einkennast af miklu vinnuálagi og streitu. Þó hafa þeir fengið fremur litla athygli í stjórnendafræðum, einkum innan heilbrigðisþjónustunnar. Við vitum til dæmis lítið um áhrif þessa krefjandi starfs á heilsu þeirra, til dæmis hvort streituvaldandi þættir í starfsumhverfinu tengjast stoðkerfisverkjum og svefni. Tilgangur þessarar rannsóknar var að skoða þessi tengsl. Um er að ræða lýsandi þversniðsrannsókn þar sem gögnum var safnað með forprófuðum spurningalista sem sendur var rafrænt á 137 hjúkrunardeildarstjóra í gegnum Outcome-kannanakerfið. Svarhlutfall var 80,9%. Lýsandi tölfræði og ályktunartölfræði var notuð við úrvinnslu gagna. Niðurstöður sýndu skýr tengsl streituvaldandi þátta í starfsumhverfi, stoðkerfisverkja og ófullnægjandi svefns eftir að stjórnað var fyrir áhrifum af aldri, hjúskaparstöðu og fjölda stöðugilda í hjúkrun á deild. Streituvaldandi þættir í starfsumhverfinu og svefn höfðu tengsl við styrkleika stoðkerfisverkja á hálssvæði og herðum og svefn hafði tengsl við styrkleika verkja í neðri hluta baks. Meiri streita þýddi meiri stoðkerfisverki á hálssvæði og í herðum að teknu tilliti til svefns. Ófullnægjandi svefn þýddi aftur meiri stoðkerfisverki frá öllum þremur líkamssvæðunum að teknu tilliti til streituvaldandi þátta. Saman skýrðu streituvaldandi þættir í starfsumhverfinu og ófullnægjandi svefn, að teknu tilliti til aldurs, hjúskaparstöðu og fjölda stöðugilda við hjúkrun á deild, 17% af heildarbreytileika í styrkleika stoðkerfisverkja á hálssvæði, 21% í herðum og 14% í neðri hluta baks. Fram kom marktæk samvirkni milli streituvaldandi þátta í starfsumhverfinu og svefns varðandi styrkleika stoðkerfisverkja á hálssvæði. Niðurstöður þessarar rannsóknar verða vonandi til þess að hugað verði betur að streituvaldandi þáttum í starfsumhverfi millistjórnenda svefni og stoðkerfisverkjum þeirra.

Introduction Sleep length has been associated with obesity and various adverse health outcomes. The possible association of sleep length and respiratory symptoms has not been previously described. The aim of this study was to investigate the association between sleep length and respiratory symptoms and whether such an association existed independent of obesity. Methods This is a multicentre, cross-sectional, population-based study performed in 23 centres in 10 different countries. Participants (n=5079, 52.3% males) were adults in the third follow-up of the European Community Respiratory Health Survey III. The mean±SD age was 54.2±7.1 (age range 39–67 years). Information was collected on general and respiratory health and sleep characteristics. Results The mean reported nighttime sleep duration was 6.9±1.0 hours. Short sleepers (<6 hours per night) were n=387 (7.6%) and long sleepers (≥9 hours per night) were n=271 (4.3%). Short sleepers were significantly more likely to report all respiratory symptoms (wheezing, waking up with chest tightness, shortness of breath, coughing, phlegm and bronchitis) except asthma after adjusting for age, gender, body mass index (BMI), centre, marital status, exercise and smoking. Excluding BMI from the model covariates did not affect the results. Short sleep was related to 11 out of 16 respiratory and nasal symptoms among subjects with BMI ≥30 and 9 out of 16 symptoms among subjects with BMI <30. Much fewer symptoms were related to long sleep, both for subjects with BMI <30 and ≥30. Conclusions Our results show that short sleep duration is associated with many common respiratory symptoms, and this relationship is independent of obesity. ; The ALEC Study is funded by the European Union's Horizon 2020 Research and Innovation programme under grant agreement No 633212. ; Peer Reviewed

To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files ; Introduction Sleep length has been associated with obesity and various adverse health outcomes. The possible association of sleep length and respiratory symptoms has not been previously described. The aim of this study was to investigate the association between sleep length and respiratory symptoms and whether such an association existed independent of obesity. Methods This is a multicentre, cross-sectional, population-based study performed in 23 centres in 10 different countries. Participants (n=5079, 52.3% males) were adults in the third follow-up of the European Community Respiratory Health Survey III. The mean +/- SD age was 54.2 +/- 7.1 (age range 39-67 years). Information was collected on general and respiratory health and sleep characteristics. Results The mean reported nighttime sleep duration was 6.9 +/- 1.0 hours. Short sleepers (= 9 hours per night) were n=271 (4.3%). Short sleepers were significantly more likely to report all respiratory symptoms (wheezing, waking up with chest tightness, shortness of breath, coughing, phlegm and bronchitis) except asthma after adjusting for age, gender, body mass index (BMI), centre, marital status, exercise and smoking. Excluding BMI from the model covariates did not affect the results. Short sleep was related to 11 out of 16 respiratory and nasal symptoms among subjects with BMI >= 30 and 9 out of 16 symptoms among subjects with BMI = 30. Conclusions Our results show that short sleep duration is associated with many common respiratory symptoms, and this relationship is independent of obesity. ; European Union

To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files. This article is open access. ; Melatonin has anticarcinogenic properties in experimental models. We undertook a case-cohort study of 928 Icelandic men without prostate cancer (PCa) nested within the Age, Gene/Environment Susceptibility (AGES)-Reykjavik cohort to investigate the prospective association between first morning-void urinary 6-sulfatoxymelatonin (aMT6s) levels and the subsequent risk for PCa, under the hypothesis that men with lower aMT6s levels have an increased risk for advanced PCa. We used weighted Cox proportional hazards models to assess the association between first morning-void aMT6s levels and PCa risk, adjusting for potential confounders. A total of 111 men were diagnosed with incident PCa, including 24 with advanced disease. Men who reported sleep problems at baseline had lower morning aMT6s levels compared with those who reported no sleep problems. Men with morning aMT6s levels below the median had a fourfold statistically significant increased risk for advanced disease compared with men with levels above the median (hazard ratio: 4.04; 95% confidence interval, 1.26-12.98). These results require replication in larger prospective studies with longer follow-up. ; In this report, we evaluated the prospective association between urinary aMT6s levels and risk of PCa in an Icelandic population. We found that lower levels of aMT6s were associated with an increased risk for advanced PCa. ; RANNIS (the Icelandic Research Fund) National Institutes of Health (NIH) National Center for Research Resources UL1-RR-025758 KL2-RR-025757 Icelandic Cancer Society NIH National Cancer Institute R25-CA-098566 T32-CA-09001-35 Prostate Cancer Foundation NIH National Institutes on Aging (NIA) N01-AG-12100 Icelandic Heart Association Icelandic Parliament NIH NIA P01-AG-009975